Answers are grounded in this paper and cite their sources.
Evaluates safety and effectiveness of intranasal esketamine in treatment-resistant depression, indicating significant therapeutic potential.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Preiß et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: